Multivalency – Designed to express multiple antigens and multiple immune modulators from a single vector. This allows the immune system to target multiple antigens from a single pathogen or multiple serotypes of a single pathogen.
Robust Immune Responses – Capable of inducing powerful, long-lived humoral and cellular immune responses against a variety of target antigens. The ability to express immune-enhancing cytokines in the same microenvironment as the target antigens provides a potential for heightened immune responses as compared to more conventional vaccines.
Minimal Development Time – Modular design of GenPhar vaccine platform reduces the time required to develop and construct vaccines.
Safety – GenPhar vaccines are safe. Vaccines tested in pre-clinical studies using 1000 times the vaccines’ effective dose showed no adverse effects. Backbone vector was tested extensively and proven safe in human clinical trials.
Stability and Versatility – Extremely stable and can be delivered in various formulations: intramuscular injection, oral ingestion, inhalation, or topical skin applications. Formulations and dosages can be customized according to the targeted pathogens, providing the means to develop vaccines against a wide range of infectious diseases.